Triamterene inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes.
- 1 June 1994
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 74 (6) , 1114-1120
- https://doi.org/10.1161/01.res.74.6.1114
Abstract
In humans, proarrhythmia during therapy with action potential-prolonging drugs can be associated with hypokalemia often provoked by concomitant administration of diuretic agents. Consequently, therapy with class III antiarrhythmics and K(+)-sparing diuretics, such as triamterene, may be indicated. Triamterene, along with its K(+)-sparing properties, exhibits other pharmacological effects. In the heart, it can increase action potential duration (guinea pig atria and papillary muscles), protect against reperfusion-induced arrhythmias (rat), and increase the QT interval (humans). Therefore, studies were undertaken to assess effects of triamterene on cardiac K+ repolarizing currents. Guinea pig ventricular myocytes were superfused at 30 degrees C with Cd(2+)-containing solution to block Isi and held at -40 mV to inactivate INa. Currents were measured in the whole-cell configuration of the patch-clamp technique. The delayed rectifier outward current (IK) was elicited by short (250-millisecond) and long (5000-millisecond) depolarizing pulses, and time-independent currents were assessed by a rapid ramp test protocol. After high-voltage long pulses (+50 mV; 5000 milliseconds), tail current amplitude of the slow component of IK (IKs) was decreased 36 +/- 6% (n = 6) and 51 +/- 8% (n = 6) by triamterene 10(-5) and 10(-4) mol/L, respectively. After low-voltage short pulses (-20 mV; 250 milliseconds), tail current amplitude corresponding essentially to the rapid component of IK (IKr) was decreased only 14 +/- 11% (n = 9) and 19 +/- 10% (n = 10) by triamterene 10(-5) and 10(-4) mol/L, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 23 references indexed in Scilit:
- Electrophysiologic effects of E-4031, a new class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmiasThe American Journal of Cardiology, 1993
- Electrophysiologic Effects of a New Class III Antiarrhythmic Agent, E-4031, on Atrial Flutter, Atrial Refractoriness, and Conduction Delay in a Canine Sterile Pericarditis ModelJournal of Cardiovascular Pharmacology, 1993
- Development of Class III Antiarrhythmic AgentsJournal of Cardiovascular Pharmacology, 1992
- RP 58866 and Its Active Enantiomer RP 62719 (Terikalant)Journal of Cardiovascular Pharmacology, 1992
- Dofetilide, a new class III antiarrhythmic agent, reduces pacing induced heterogeneity of repolarisation in vivoCardiovascular Research, 1992
- Modulation of potassium channels by antiarrhythmic and antihypertensive drugs.Hypertension, 1992
- Effects of Ibutilide on Spontaneous and Induced Ventricular Arrhythmias in 24-Hour Canine Myocardial InfarctionJournal of Cardiovascular Pharmacology, 1992
- Pharmacokinetics of triamterene and its metabolite in manJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.Circulation, 1981
- Increasing the inotropic effect and toxic dose of digitalis by the administration of antikaliuretic drugs—further evidence for a cardiac effect of diuretic agentsAmerican Heart Journal, 1975